Form 4: Arteris Director Wayne Cantwell Receives RSU Grant

Director Wayne Cantwell acquired 7,839 restricted stock units in Arteris, Inc. as part of an equity compensation grant.

Summary

• Director Wayne Cantwell was granted 7,839 restricted stock units (RSUs) on June 2, 2026.
• Each RSU represents a contingent right to receive one share of Arteris, Inc. common stock.
• The grant was valued at an average trading price of $31.89 per share.
• The RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date or immediately before the next annual stockholders meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon the reporting person continuing to provide services to the Board through the vesting date.

Future Outlook

The RSUs will vest in full on the earlier of the first anniversary of the grant date or immediately before the annual meeting of the Issuer's stockholders following the grant date.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder interests in the semiconductor and software IP industry.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard practices for publicly traded technology companies.
• The vesting schedule aligns with typical one-year director equity retention cycles.

Stakeholder Impact

• Minor dilution impact on existing shareholders upon eventual vesting and issuance of shares.

Next Steps

• Vesting of the 7,839 RSUs on the earlier of the first anniversary or the next annual meeting.

Key Dates

Keywords

Arteris, AIP, Director, Equity Grant, Insider Transaction, RSU